GlassScriptPhysician profile
Matthew Adasofunjo
NPI 1538481197
$1,070.76
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $30.22 · 2021: $62.06 · 2024: $978.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $792 · Food and Beverage: $186.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $792.48 |
| Food and Beverage | $186.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Modernatx, INC. | $978.48 | 2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $17.14 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $16.47 | 2019 | |
| Janssen Pharmaceuticals, INC | $15.95 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $14.74 | 2021 | |
| Abbvie INC. | $14.23 | 2021 | |
| Allergan, INC. | $13.75 | 2019 |
2 companies reported research payments only; those appear in the research section below.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Adasofunjo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.